Search
for
Sort by
Research 271–300 of 1000+
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES
- MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Ruxolitinib found to cause eyelash growth: a case report
- Mechanisms of autophagy and their implications in dermatological disorders
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Alopecia Areata: Current and Emerging Therapies
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Baricitinib for the Treatment of Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Leptin and the skin: a new frontier
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Treating Alopecia Areata: Current Practices Versus New Directions
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Emerging drugs for alopecia areata: JAK inhibitors
- The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
- Treatments options for alopecia
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Alopecia in general medicine